SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
77.10
+0.10 (0.13%)
Oct 31, 2025, 1:11 PM CST
SYN-TECH Chem. & Pharm. Revenue
SYN-TECH Chem. & Pharm. had revenue of 324.84M TWD in the quarter ending June 30, 2025, a decrease of -5.30%. This brings the company's revenue in the last twelve months to 1.29B, up 5.79% year-over-year. In the year 2024, SYN-TECH Chem. & Pharm. had annual revenue of 1.26B with 12.83% growth.
Revenue (ttm)
1.29B
Revenue Growth
+5.79%
P/S Ratio
2.67
Revenue / Employee
5.66M
Employees
227
Market Cap
3.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.26B | 142.98M | 12.83% |
| Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
| Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
| Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
| Dec 31, 2020 | 983.79M | 37.38M | 3.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |